INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1185375169 trial oversight]( "A Promising Rebound in Clinical Trials")
A Promising Rebound in Clinical TrialsThis report explores how clinical trials bounced back in 2023 from their decline a year earlier despite continued geopolitical, regulatory, and pricing pressures.
-
![Emvenio clinical research]( "Providing Access To Patients")
Providing Access To PatientsWe believe that delivering meaningful results begins with meeting patients where they are — whether in their homes, within their communities, or in familiar gathering places.
-
![GettyImages-1279370267 opthalmic study]( "The Hidden Complexity Of Ophthalmic Protocol Requirements")
The Hidden Complexity Of Ophthalmic Protocol RequirementsExplore the critical role of meticulously planning ophthalmic assessments in clinical trials, highlighting their potential risks and complexities.
-
![Doctors board room meeting-GettyImages-1365555907]( "10 Ways To Elevate Your Investigators' Meeting")
10 Ways To Elevate Your Investigators' MeetingLearn how you can take your next Investigators' Meeting from every day to exceptional with 10 top tips from the clinical meeting planning experts at Scout.
-
Leveraging DHTs To Improve Data Collection And Analysis2/25/2025
How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?
-
A 2025 Survey Report Uncovers The Top 5 Clinical Trial Cost Insights4/22/2025
In this 2025 survey of over 100 U.S. clinical trial participants and caregivers, we reveal that most individuals join trials seeking life-saving treatment, not financial gain.
-
The Implications Of Semaglutide's Connect To Increased Risk Of NAION2/18/2025
Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
-
How To Improve Patient ID And Retention In Chronic Disease Trials4/23/2026
Leveraging primary care for chronic disease studies can accelerate patient identification, access to underrepresented populations, and improve retention rates.
-
Understanding Subjective Outcome Measures In HAP Studies4/28/2026
Understanding how a participant "feels" is essential for drug safety. Explore how subjective measures and specialized training provide the data needed to evaluate human abuse potential.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1325251634-doctor-patient-blood-pressure-visit]( "Recruitment Strategies: A Behind The Scenes Look")
Explore a dynamic recruitment strategy being used to address the growing demand for participants in early-stage clinical trials while overcoming regulatory and ethical challenges.
-
![Eye Drop iStock-1182318206]( "Comprehensive Services For Ophthalmology Drug Development")
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
![ai-in-healthcare-GettyImages-1333328712]( "TrialKit AI Timeline Value")
Automate protocol design, database builds, and validation to cut study setup from months to days — enabling faster analytics, earlier insights, and trial simulation.
-
![GettyImages-1492337134 doctor notes]( "Clinical Operations And Project Management")
Consider the benefits of an integrated operations and project management approach across all phases and regions.
-
![GettyImages-1212821220 diversity]( "Intelligent Trials - Diversity")
Medidata AI’s Intelligent Trials solution provides insights that allow you to take action to improve study diversity during the planning stages.
